We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Genetic Determinant Governs H Pylori Behavior

By Biotechdaily staff writers
Posted on 02 Jun 2006
Researchers have found that the ulcer-causing bacteria Helicobacter pylori requires a specific gene to be able to follow the pH gradient from the acidic reaches of the stomach to the more alkaline region of the gastric mucosa. More...
Mutants lacking this gene were unable to infect a line of susceptible mice.

Investigators at the University of Virginia (Charlottesville, USA) used a microscope slide-based pH gradient assay and video data collection system to document pH-tactic behavior. In response to hydrochloric acid, H pylori changed its swimming pattern from straight-line random swimming to arcing or circular patterns that moved the motile population away from the strong acid. Bacteria in more-alkaline regions did not swim toward the acid.

To identify the chemoreceptors responsible for the transduction of pH-tactic signals, genetic engineering was used to construct mutations in each of the four known chemoreceptor genes (tlpA, tlpB, tlpC, and tlpD) in H pylori strain SS1 and a motile variant of strain KE26695. Results of studies with these mutant strains published in the April 2006 edition of the Journal of Bacteriology revealed that only tlpB mutants were defective for pH taxis.

While tlpA, tlpC, and tlpD mutants were able to colonize mice to near wild-type levels, tlpB mutants failed to infect a line of highly permissive C57BL/6 mice. Replacement of tlpB restored both pH taxis and infectivity for mice.

"Because pH sensing ability is essential for colonization and persistence in the stomach lining tissue, the tlpB pH receptor might represent a novel target for the development of treatments that can interfere with this behavior,” said senior author Dr. Paul S. Hoffman, professor of infectious diseases at the University of Virginia. "H pylori infections occur most often in developing countries that cannot afford the cost of miracle drugs. Perhaps a narrow-spectrum drug designed to block the chemoreceptor would be less expensive to develop.”



Related Links:
University of Virginia

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The POC diagnostic test aims to use fingerstick blood, serum, or plasma sample to detect typhoid fever (Photo courtesy of Adobe Stock)

POC Test Uses Fingerstick Blood, Serum, Or Plasma Sample to Detect Typhoid Fever

Typhoid fever is an acute febrile illness caused by Salmonella enterica serovar Typhi (S. Typhi) and affects an estimated 11–21 million people globally each year, resulting in approximately 128,000–161,000... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.